MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma
Clinical trial NCT03979651 · COMPLETED
Trial details
- NCT number
- NCT03979651
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-15
- Primary completion
- 2023-01-03
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.